Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04617938 · ClinicalTrials.gov registry record · NA

TACUNA (Traditions and Connections for Urban Native Americans)

A NA study, sponsored by RAND.

Completed
Registry status
NA
Development phase
541
Enrollment target

NCT04617938 is a NA study that has completed, run by RAND. The registered enrollment target is 541 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04617938, a NA study, has completed, sponsored by RAND.

COMPLETED
Registry status
NA
Development phase
541 participants
Enrollment target

Study Summary

This study responds to Request For Application-DA-19-035, HEAL (Helping End Addiction Long Term) initiative: Preventing OUD in Older Adolescents and Young Adults (ages 16-30) by developing and implementing a culturally centered intervention to address opioid use among urban AI/AN emerging adults in California. The primary goal of this study is to compare AI/AN emerging adults who receive TACUNA plus a Wellness Circle (WC) to those AI/AN emerging adults who receive an opioid education workshop on outcomes (e.g., opioid misuse and alcohol and other drug use) over a period of 12 months. TACUNA will be a motivational interviewing group intervention that incorporates traditional practices and discussion of how to cultivate healthy social networks and cultural worlds. The Wellness gathering will be for emerging adults and people in their social network, and will focus on how social networks and cultural connectedness influence healthy behaviors. Opioid education will focus on discussion of opioid misuse within the AI/AN urban community and ways to reduce use in a culturally appropriate manner. Investigators expect those who receive TACUNA + WG will report less opioid and AOD (alcohol and other drug) use frequency, fewer consequences, less time spent around peers who use opioids and AOD, and less perceived prevalence of peer use compared to opioid education over a period of 12 months. Also, investigators will evaluate the intervention's effects on secondary outcomes of social networks and cultural connectedness. Survey data is collected at baseline, 3-months, 6-months and 12-months. Longitudinal analyses will compare intervention participant and control participants on primary and secondary outcomes.

Interventions

  • BEHAVIORAL TACUNA plus Wellness Circle
  • BEHAVIORAL Opioid Education Workshop

Trial Details

FieldValue
Enrollment Target 541 participants
Start Date 2020-11-23
Est. Completion 2025-07-28
Phase NA

Sponsor

RAND

78 total trials

What the Registry Record Tells You About NCT04617938

The ClinicalTrials.gov registry entry for NCT04617938 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 541 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RAND, which has 78 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which TACUNA plus Wellness Circle is the first listed.

NCT04617938 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04617938 about?

NCT04617938 is a clinical study titled "TACUNA (Traditions and Connections for Urban Native Americans)". This study responds to Request For Application-DA-19-035, HEAL (Helping End Addiction Long Term) initiative: Preventing OUD in Older Adolescents and Young Adults (ages 16-30) by developing and implementing a culturally centered intervention to address opioid use among urban AI/AN emerging adults in ...

What is the current status of trial NCT04617938?

This trial is currently completed. It is a NA study. The enrollment target is 541 participants. The study started on 2020-11-23. Estimated completion is 2025-07-28.

What interventions are being tested in trial NCT04617938?

The interventions under investigation include: TACUNA plus Wellness Circle (BEHAVIORAL), Opioid Education Workshop (BEHAVIORAL).

Who is sponsoring clinical trial NCT04617938?

This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.